China SXT Pharmaceuticals (SXTC) Enterprise Value: 2018-2025
- China SXT Pharmaceuticals' Enterprise Value rose 132.97% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.8 million, marking a year-over-year increase of 32.19%. This contributed to the annual value of -$8.4 million for FY2025, which is 13.61% up from last year.
- According to the latest figures from Q3 2025, China SXT Pharmaceuticals' Enterprise Value is $3.4 million, which was up 141.13% from -$8.4 million recorded in Q1 2025.
- Over the past 5 years, China SXT Pharmaceuticals' Enterprise Value peaked at $15.2 million during Q1 2021, and registered a low of -$16.0 million during Q3 2023.
- Moreover, its 3-year median value for Enterprise Value was -$10.1 million (2024), whereas its average is -$9.3 million.
- Per our database at Business Quant, China SXT Pharmaceuticals' Enterprise Value soared by 179.30% in 2021 and then tumbled by 632.38% in 2022.
- Quarterly analysis of 5 years shows China SXT Pharmaceuticals' Enterprise Value stood at $2.6 million in 2021, then tumbled by 632.38% to -$14.0 million in 2022, then fell by 13.97% to -$16.0 million in 2023, then soared by 34.48% to -$10.5 million in 2024, then skyrocketed by 132.97% to $3.4 million in 2025.
- Its Enterprise Value was $3.4 million in Q3 2025, compared to -$8.4 million in Q1 2025 and -$10.5 million in Q3 2024.
